Catalyst

Slingshot members are tracking this event:

TESARO (TSRO) Presents Three Posters on Niraparib at the 2015 AACR-NCI-EORTC Conference on Molecular Targets and Cancer Therapeutics

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
TSRO

100%

Additional Information

Clinical Data Homologous recombination deficiency (HRD) score enriches for niraparib sensitive high grade ovarian tumors
http://www.tesarobio...
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 09, 2015
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Niraparib, Homologous Recombination Deficiency Analysis, Phase 3, Ovarian Cancer